Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


New Zealand taking the lead with 3D scanner

Canterbury and New Zealand taking the lead with 3D scanner to help reduce diseases

June 22, 2014

The University of Canterbury and New Zealand is leading the world’s pre-clinical imaging market with research work on its commercial 3D scanner improving the treatment of diseases.

The university’s spin-out company‘s MARS-Bioimaging scanner can look inside the body to examine molecular structures, tissues, diagnose common illnesses such as the build-up of plaque in heart disease and also cartilage and arthritis. It also enables drug delivery systems that allow researchers to follow drugs in the body to help the fight against cancer and joint diseases.

Associate Professor Anthony Butler says it is important for New Zealand to have a world-leading biomedical research tools so health researchers can understand new information.

``We have been the first in the world to explore the scanner and its applications. While others theorise about scanner uses we can actually test them.

``Five years ago there were only a small number of people in the world doing this research. There are now special editions of journals covering the topics and conferences. The preclinical imaging market involving scanners used in medical research is worth about $US200 million a year and growing 16 percent annually.’’

MARS-Bioimaging last year won the Canterbury Regional Deloitte Fast 50 Rising Star Award. The University of Canterbury, which has a share in the company, has a Ministry of Business, Innovation and Employment bid under consideration with a goal is to build a scanner to use on patients.

``If we have success with the bid we expect to be safely scanning large animals such as sheep in about three years and able to undertake human clinical trials in five years’ time. The scanner will be hosted in Otago University’s Christchurch Medical School. Several local companies MBI, Interlink Research and Shamrock are partners. International partners include CERN, GE Healthcare and Kromek.

``We face a number of technical challenges such as the quality of sensor materials and coping with the high power of the x-ray tubes used for human scanning.

``On the clinical side we know there is likely to be benefit for monitoring drug delivery agents and joint implant imaging. The purpose of a human scanner for clinical trials is to evaluate how this new information translates to improved human diagnosis and management.

``The University of Canterbury has $4.5 million of Government funding from 2008 to 2014 to work on the project, has spent significant time and money building scanners. MARS-Bioimaging is selling the technology -components and scanners – internationally,’’ Associate Professor Prof Butler says.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Half Full: Dairy Payouts Steady, Cash Will Be Tight

Industry body DairyNZ is advising farmers to focus on strong cashflow management as they look ahead to the 2015-16 season following Fonterra's half-year results announcement today. More>>

ALSO:

First Union: Cotton On Plans To Use “Tea Break” Law

“The Prime Minister reassured New Zealanders that ‘post the passing of this law, will you all of a sudden find thousands of workers who are denied having a tea break? The answer is absolutely not’... Cotton On is proposing to remove tea and meal breaks for workers in its safety sensitive distribution centre. How long before other major chains try and follow suit?” More>>

ALSO:

Scoop Business: NZ-Korea FTA Signed Amid Spying, Lost Sovereignty Claims

A long-awaited free trade agreement between New Zealand and South Korea has been signed in Seoul by Prime Minister John Key and the Korean president, Park Geun-hye. More>>

ALSO:

PM Visit: NZ And Viet Nam Agree Ambitious Trade Target

New Zealand and Viet Nam have agreed an ambitious target of doubling two-way goods and service trade to around $2.2 billion by 2020, Prime Minister John Key has announced. More>>

ALSO:

Scoop Business: NZ Economy Grows 0.8% In Fourth Quarter

The New Zealand economy expanded in the fourth quarter as tourists drove growth in retailing and accommodation, and property sales increased demand for real estate services. More>>

ALSO:

Scoop Business: RBNZ’s Wheeler Keeps OCR On Hold, No Rate Hikes Ahead

The Reserve Bank has removed the prospect of future interest rate hikes from its forecast horizon as a strong kiwi dollar and cheap oil hold down inflation, and the central bank ponders whether to lower its assessment of where “neutral” interest rates should be. The kiwi dollar gained. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news